|
FSTL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84659999999948E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64599999999959E-05 |
| Normal-vs-Stage2 |
8.97399999866266E-08 |
| Normal-vs-Stage3 |
3.742000E-02 |
| Normal-vs-Stage4 |
2.077800E-01 |
| Stage1-vs-Stage2 |
2.830100E-02 |
| Stage1-vs-Stage3 |
2.231600E-01 |
| Stage1-vs-Stage4 |
1.744780E-01 |
| Stage2-vs-Stage3 |
9.818000E-03 |
| Stage2-vs-Stage4 |
1.346200E-02 |
| Stage3-vs-Stage4 |
7.155800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.987100E-04 |
| Normal-vs-AfricanAmerican |
1.942230E-01 |
| Normal-vs-Asian |
3.244900E-03 |
| Caucasian-vs-AfricanAmerican |
7.564200E-01 |
| Caucasian-vs-Asian |
6.133000E-01 |
| AfricanAmerican-vs-Asian |
5.489600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.183700E-04 |
| Normal-vs-Female |
2.15699999999153E-05 |
| Male-vs-Female |
9.011000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.801500E-04 |
| Normal-vs-Age(41-60Yrs) |
3.73230000000335E-05 |
| Normal-vs-Age(61-80Yrs) |
2.564100E-03 |
| Normal-vs-Age(81-100Yrs) |
9.164200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.809200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.896200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.046400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.739400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.601200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.119600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.331420E-01 |
| Classical-VS-Follicular |
2.85039991609892E-10 |
| Classical-VS-Other |
4.773400E-01 |
| Classical-VS-Normal |
2.323000E-03 |
| Tall-VS-Follicular |
5.377000E-04 |
| Tall-VS-Other |
2.342600E-01 |
| Tall-VS-Normal |
7.941600E-01 |
| Follicular-VS-Other |
1.974570E-01 |
| Follicular-VS-Normal |
1.73561165439651E-12 |
| Other-VS-Normal |
2.593800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.84489999838422E-08 |
| Normal-vs-N1 |
1.382490E-02 |
| N0-vs-N1 |
1.371980E-01 |
|
|
